O-(((1R)-((N-phenylmethoxycarbonyl-L-alanyl)amino)ethyl)hydroxyphosphono)-L-benzylacetic acid

O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-alanyl)amino)ethyl)hydroxyphosphono)-L-benzylacetic acid is a synthetic small molecule classified as an alpha amino acid amide derivative. It features a phosphonate group and is structurally related to peptide-like enzyme inhibitors. The compound has been studied primarily in experimental settings and does not have any approved therapeutic indications or known clinical development beyond preclinical research. Its mechanism of action is presumed to involve inhibition of proteases or peptidases due to its structural similarity to transition-state analogs for such enzymes[3][4][5]. No specific developer or manufacturer information is available.

Other names

(2S)-2-{[(R)-[(1R)-1-({N-[(benzyloxy)carbonyl]-L-alanyl}amino)ethyl](hydroxy)phosphoryl]oxy}-3-phenylpropanoic acidBenzenepropanoic acid, alpha-[[(R)-hydroxy[(1R,1R)-1-[[(2S)-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]propyl]amino]ethyl]phosphinyl]oxy]-, (alphaS)